Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Radiology

Volumn 247, Issue 1, 2008, Pages 170-178

  Danchaivijitr, Nasuda ^a,b   Waldman, Adam D ^a,b,c   Tozer, Daniel J ^a   Benton, Christopher E ^a   Caseiras, Gisele Brasil ^a,d   Tofts, Paul S ^a   Rees, Jeremy H ^a   Jäger, H Rolf ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN BIOPSY; BRAIN BLOOD FLOW; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NEUROIMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; BRAIN CIRCULATION; BRAIN TUMOR; DISEASE COURSE; DISEASE FREE SURVIVAL; LONGITUDINAL STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; SUPRATENTORIAL NEOPLASMS;

EID: 42449135741     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2471062089     Document Type: Article

References (21)

1. Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 2003;99(5):854-862.
2. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366(9490):985-990.
3. Daumas-Duport C, Tucker ML, Kolles H, et al. Oligodendrogliomas. II. A new grading system based on morphological and imaging criteria. J Neurooncol 1997;34(1):61-78.
4. Mihara F, Numaguchi Y, Rothman M, Sato S, Fiandaca MS. MR imaging of adult supratentorial astrocytomas: an attempt of semi-automatic grading. Radiat Med 1995;13(1):5-9.
5. Pierallini A, Bonamini M, Bozzao A, et al. Supratentorial diffuse astrocytic tumours: proposal of an MRI classification. Eur Radiol 1997;7(3):395-399.
6. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? a population study. Neurology 2002;59(6):947-949.
7. White ML, Zhang Y, Kirby P, Ryken TC. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 2005;26(4):784-790.
8. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171(6):1479-1486.
9. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191(1):41-45.
10. Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43(6):845-853.
11. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24(10):1989-1998.
12. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25(2):214-221. [Published correction appears in AJNR Am J Neuroradiol 2004;25(3):B1.]
13. Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22(7):1306-1315.
14. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44(8):656-666.
15. Maia AC Jr, Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26(4):777-783.
16. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88(3):513-520.
17. Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusionMR imaging - prediction of patient clinical response. Radiology 2006;238(2):658-667.
18. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223(1):11-29.
19. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224(3):797-803.
20. 2*-w DCE-MRI: blood perfusion and volume estimation using bolus tracking. In: Tofts P, ed. Quantitative MRI of the brain. Chichester, England: Wiley, 2003; 365-412.
21. Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26(2):266-273.